| Publications: |
| Synthesis: |
|---|
| Li S, Peck-Radosavljevic M, Koller E, Koller F, Kaserer K, Kreil A, Kapiotis S, Hamwi A, Weich HA, Valent P, et al. Characterization of (123)I-vascular endothelial growth factor-binding sites expressed on human tumour cells: possible implication for tumour scintigraphy. Int J Cancer. 2001; 91(6):789-796Yoshimoto M, Kinuya S, Kawashima A, Nishii R, Yokoyama K, Kawai K Radioiodinated VEGF to image tumor angiogenesis in a LS180 tumor xenograft model. Nuclear Medicine and Biology. 2006; 33 (8): 963-969Bart Cornelissena, Ruth Oltenfreitera, Veerle Kersemansa, Ludovicus Staelensa, Francis Frankenneb, Jean-Michel Foidartb, Guido Slegersa. In vitro and in vivo evaluation of [123I]-VEGF165 as a potential tumor marker. Nuclear Medicine and Biology. 2005; 33 (5): 431-436Specific activity reported: 1.66 GBq/nmol |
| In vitro analysis: |
|---|
| Li S, Peck-Radosavljevic M, Koller E, Koller F, Kaserer K, Kreil A, Kapiotis S, Hamwi A, Weich HA, Valent P, et al. Characterization of (123)I-vascular endothelial growth factor-binding sites expressed on human tumour cells: possible implication for tumour scintigraphy. Int J Cancer. 2001; 91(6):789-796.Yoshimoto M, Kinuya S, Kawashima A, Nishii R, Yokoyama K, Kawai K Radioiodinated VEGF to image tumor angiogenesis in a LS180 tumor xenograft model. Nuclear Medicine and Biology. 2006; 33 (8): 963-969Li S, Peck-Radosavljevic M, Kienast O, Preitfellner J, Havlik E, Schima W, Traub-Weidinger T, Graf S, Beheshti M, Schmid M, et al. Iodine-123-vascular endothelial growth factor-165 (123I-VEGF165). Biodistribution, safety and radiation dosimetry in patients with pancreatic carcinoma. Q J Nucl Med Mol Imaging. 2004; 48(3):198-206Bart Cornelissena, Ruth Oltenfreitera, Veerle Kersemansa, Ludovicus Staelensa, Francis Frankenneb, Jean-Michel Foidartb, Guido Slegersa. In vitro and in vivo evaluation of [123I]-... |
| Animal Studies: |
|---|
| Li S, Peck-Radosavljevic M, Koller E, Koller F, Kaserer K, Kreil A, Kapiotis S, Hamwi A, Weich HA, Valent P, et al. Characterization of (123)I-vascular endothelial growth factor-binding sites expressed on human tumour cells: possible implication for tumour scintigraphy. Int J Cancer. 2001; 91(6):789-796.Yoshimoto M, Kinuya S, Kawashima A, Nishii R, Yokoyama K, Kawai K Radioiodinated VEGF to image tumor angiogenesis in a LS180 tumor xenograft model. Nuclear Medicine and Biology. 2006; 33 (8): 963-969Bart Cornelissena, Ruth Oltenfreitera, Veerle Kersemansa, Ludovicus Staelensa, Francis Frankenneb, Jean-Michel Foidartb, Guido Slegersa. In vitro and in vivo evaluation of [123I]-VEGF165 as a potential tumor marker. Nuclear Medicine and Biology. 2005; 33 (5): 431-436 |
| Clinical Studies: |
|---|
| Li S, Peck-Radosavljevic M, Kienast O, Preitfellner J, Hamilton G, Kurtaran A, Pirich C, Angelberger P, Dudczak R. Imaging gastrointestinal tumours using vascular endothelial growth factor-165 (VEGF165) receptor scintigraphy. Ann Oncol. 2003; 14(8):1274-1277Li S, Peck-Radosavljevic M, Kienast O, Preitfellner J, Havlik E, Schima W, Traub-Weidinger T, Graf S, Beheshti M, Schmid M, et al. Iodine-123-vascular endothelial growth factor-165 (123I-VEGF165). Biodistribution, safety and radiation dosimetry in patients with pancreatic carcinoma. Q J Nucl Med Mol Imaging. 2004; 48(3):198-206.Shuren Li, Karl Roessler, Hossen Amadzadehfar, Elke Grumbeck, Karolina Wiesner, Christian Nasel, Christine Marosi, Peter Angelberger, Robert Dudczak. Imaging glioblastoma using iodine-123 labelled vascular endothelial growth factor-165 (123I-VEGF165). J Nucl Med. 2006; 47 (Supplement 1):80PS. Graf, M. Beheshti, O. Kienast, S. Oezer, P. Angelberger, R. Dudczak, S. Shuren Li. Myocardial scintigraphy in patients with corona... |
|
|---|